Borosil Scientific Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
BOROSCI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Borosil Scientific Limited reported healthy FY25 results with standalone revenue rising 10% to Rs. 39,249 lakh (from Rs. 35,646 lakh) and standalone profit after tax up 11% to Rs. 3,502 lakh (from Rs. 3,146 lakh). Consolidated revenue grew 11% to Rs. 43,849 lakh with consolidated PAT up 14% to Rs. 2,672 lakh. EPS stood at Rs. 3.94 (standalone) vs Rs. 3.55 last year. The Scientific segment (lab glassware, equipment, process systems) was the key growth driver, while the Glassware segment reported standalone losses of Rs. 1,424 lakh for the year. The board also proposed seeking shareholder approval to raise up to Rs. 250 crore via methods like QIP, FPO, or FCCBs. The auditor (Chaturvedi & Shah LLP) issued an unmodified (clean) opinion on both standalone and consolidated results.
Solid top-line and bottom-line growth with a clean audit opinion is positive for shareholders. However, the Glassware segment's deepening losses and the proposal to raise up to Rs. 250 crore in fresh capital could lead to potential equity dilution, which may be a watch point for existing investors.